Use of low-dose human chorionic gonadotropin (hCG) for final follicular maturation in ovulatory women treated by intrauterine insemination

Middle East Fertility Society Journal

Volumn 11, Issue 3, 2006, Pages 210-215

  Dehghani Firouzabady, Razeih ^a   Asgharnia, Maryam ^a   Tayebi, Naeimeh ^a   Kalantar, Seyyed Mehdi ^a  

^a Yazd Medical Sciences University   (Iran)

Author keywords

Intrauterine insemination (IUI); Low dose human chorionic gonadotropin (hCG); Ovarian stimulation

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CELL SIZE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; ENDOMETRIUM; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HUMAN; INTRAUTERINE INSEMINATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPONTANEOUS ABORTION; THICKNESS; TRANSVAGINAL ECHOGRAPHY; TWIN PREGNANCY;

EID: 33947205010     PISSN: 11105690     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hall JE, Schoenfeld DA, Martin KA, Crowley WF J. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinal Metab 1992; 74:600-7.
2. Filicori M, Santoro N, Merriam GR, Crowley WF Jr. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986; 62:1136-44.
3. Kilani Z, Dakkak A, Ghunaims, Cognigni GE, Taberelli C, Parmegiani L, et al. A prospective, randomized, controlled trial comparing highly purified hMG with recombinant FSH in women undergoing ICSI: Ovarian response and clinical outcomes. Hum Reprod 2003; 18; 1194-9.
4. Filicori M, Cognigni GE, Pocognoli P, Taberelli C, Ferlini F, Perri T, et al. Comparison of controlled ovarian hyperstimulation with human menopausal gonadotropin or recombinant follicle- stimulating hormone. Fertil Steril 2003; 80:390-7.
5. Zeleznik AJ, Hillier SG. The role of gonadotropins in the selection of the preovulatory follicle. Clin Obstet Gynecol 1984; 27:927-40.
6. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al. The use of luteinizing hormone activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543-57.
7. Filicori M, Cognigni GE, Taberelli C, Pocognoli P, Taraborrelli S, Spettoli D, et al. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women . J Clin Endocrinol Metab 2002; 87:1156-61.
8. Filicori M, Cognigni GE, Taraborrelli S, Parmegiani L, Bernardi S, Ciampaglia W. Intracytoplasmic sperm injection pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertil Steril 2002; 78:414-6.
9. Sullivan MW, Steward - Akers A, Krasnow JS , Berga SL, Zeleznik A: Ovarian responses in women to recombinant Follicle-Stimulating hormone and luteinizing hormone(LH): A role for LH in the final stages of follicular maturation. J Clin Endocrinal Metab 1999; 84:228-232.
10. Branigan EF, Estes A. Use of micro-dose human chorionic gonadotropin (hCG) after clomiphene citrate (CC) to complete folliculogenesis in previous CC-resistant anovulation. Am J Obstet Gynecol.2005; 192(6):1890-4.
11. Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE Disappearance of exogenously administered human chorionic .gonadotropin. Fertil Steril 1989; 52:398-400.
12. Ross GT. Clinical relevance of research on the structure of human chorionic gonadotropin. Am J Obstet Gynecol. 1997; 129:795-808.
13. Stokman PG, de Leeuw R, van den wijngaard HA, Kloosterboer HJ, Vemer HM, Sanders AL. Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil Steril 1993; 60:175-8.
14. The European Recombinant LH study Group. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures; results of a multicenter double-blind study. J Clin Endocrinol Metab.2001; 86:2607-18.
15. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotropin administration. Hum Reprod (in press)
16. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, Tabarelli De Fatis C, et al. Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J Clin Endocrinol Metab 2001; 86:337-43.
17. Filicori M, Cognigni GE, Gamberini E, Parmegiani L, Troilo E, Roset B. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertil Steril 2005; 84(2):394-401.
18. Lee A. Miller KA, Elkinnd-Hirsch KE, Scott RT. The "uncoast" use of low- dose hCG alone to complete ovarian folliculogenesis in a high responder. Fertil Steril 2004; 82:S120.
19. The European Recombinant Human LH study group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced Follicular development in LH-and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998; 83:1507-14.
20. Kyono K, Fuchinoue K, Nakajo Y, Yagi A, Sasaki K. A prospective randomized study of three ovulation induction protocols for IVF: GnRH agonist versus antagonist with and without low-dose hCG. Fertil Steril2004; 82:S31.
21. Lee KL, Couchman GM, Walmer DK. Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation. J Assist Reprod Genet 2005; 22(1):37-40